Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors The study included 17,292 unrelated ...

Hematopoietic stem cell transplantation (HSCT) is an established therapeutic intervention for a variety of haematological malignancies and non-malignant disorders. Central to the success of HSCT is ...

The FDA accepted a Biologics License Application for imlifidase for the desensitization treatment of highly sensitized adult kidney transplant patients.

A hidden donor-recipient HLA mismatch may increase the risk of life-threatening immune complications after cord blood ...

Omixon has launched NanoTYPE MONO™ and MONOall™ RUO, a single-plex human leukocyte antigen amplification kit compatible with Oxford Nanopore’s MinION™ platform. According to the company, the NanoTYPE ...